Vimarsana
Biggest News Aggregation in the World

Page 5 - Comparative Effectiveness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comparative Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comparative Effectiveness Today - Breaking & Trending Today

Safety, Efficacy of Analgesics for Low Back Pain 'Uncertain' - Vimarsana News

Safety, Efficacy of Analgesics for Low Back Pain 'Uncertain'

A new review reveals considerable uncertainty around the efficacy and safety of analgesic medications for acute low back pain.

Older Patients Shown to Exhibit Better Pain Relief, Quality of Life Than Younger Patients Following Total Knee Arthroplasty - Vimarsana News

Older Patients Shown to Exhibit Better Pain Relief, Quality of Life Than Younger Patients Following Total Knee Arthroplasty

/PRNewswire/ -- Patients aged 55 and younger were found to have worse pain, function and quality of life following total knee arthroplasty (TKA) compared to...

Digital Therapeutics Could Help Patients With IBS - Vimarsana News

Digital Therapeutics Could Help Patients With IBS

Additional validation studies are needed, but these tools may improve clinical management.

Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights - Vimarsana News

Prothena Corporation plc: Prothena Reports Fourth Quarter and Full Year 2022 Financial Results, and Provides Financial Guidance and Business Highlights

Net cash used in operating and investing activities was $5.1 million in the fourth quarter and $109.3 million for the full year of 2022; quarter-end cash and restricted cash position was $712.6 million

Drugs Advertised on TV Aren't Better Than Existing Options: Study - Vimarsana News

Drugs Advertised on TV Aren't Better Than Existing Options: Study

Manufacturers spend more on advertising for those less beneficial drugs than for ones that work better.